Traversa Secures $5M in Series B, Nears Close of Research Deals for Delivery Technology
April 02, 2009
Traversa Secures $5M in Series B, Nears Close of Research Deals for Delivery Technology
By Doug Macron
The company also plans to begin a series of non-human primate studies to test its delivery technology, a move that is largely driven by the demands of potential big pharma partners for better data before forming alliances.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.